Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase ITK/TSK |
---|
Ligand | BDBM350321 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2147389 (CHEMBL5031735) |
---|
IC50 | 0.000±n/a nM |
---|
Citation | Sabat, M; Dougan, DR; Knight, B; Lawson, JD; Scorah, N; Smith, CR; Taylor, ER; Vu, P; Wyrick, C; Wang, H; Balakrishna, D; Hixon, M; Madakamutil, L; McConn, D Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 ( J Med Chem64:12893-12902 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase ITK/TSK |
---|
Name: | Tyrosine-protein kinase ITK/TSK |
Synonyms: | EMT | ITK | ITK_HUMAN | Kinase EMT | LYK | T-cell-specific kinase | Tyrosine-protein kinase ITK | Tyrosine-protein kinase ITK (ITK) | Tyrosine-protein kinase Lyk |
Type: | Protein |
Mol. Mass.: | 71839.20 |
Organism: | Homo sapiens (Human) |
Description: | Q08881 |
Residue: | 620 |
Sequence: | MNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRTLKGSIELSRI
KCVEIVKSDISIPCHYKYPFQVVHDNYLLYVFAPDRESRQRWVLALKEETRNNNSLVPKY
HPNFWMDGKWRCCSQLEKLATGCAQYDPTKNASKKPLPPTPEDNRRPLWEPEETVVIALY
DYQTNDPQELALRRNEEYCLLDSSEIHWWRVQDRNGHEGYVPSSYLVEKSPNNLETYEWY
NKSISRDKAEKLLLDTGKEGAFMVRDSRTAGTYTVSVFTKAVVSENNPCIKHYHIKETND
NPKRYYVAEKYVFDSIPLLINYHQHNGGGLVTRLRYPVCFGRQKAPVTAGLRYGKWVIDP
SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ
LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH
RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD
VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE
DRPAFSRLLRQLAEIAESGL
|
|
|
BDBM350321 |
---|
n/a |
---|
Name | BDBM350321 |
Synonyms: | (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1H-1,2,4-triazol-5(4H)-one | US10307414, Example 5 | US11786608, Example 1 | US9801872, Example 5 |
Type | Small organic molecule |
Emp. Form. | C18H17N5O3 |
Mol. Mass. | 351.3593 |
SMILES | C=CC(=O)N1CC[C@@H](C1)Oc1nc(cc2ccccc12)-c1n[nH]c(=O)[nH]1 |r| |
Structure |
|